Cargando…
CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects
Post-mortem studies consistently show evidence of reduced synaptic protein levels in patients with schizophrenia. Clinically high-risk subjects show a steeper decrease in grey matter thickness and in vitro modeling using patient-derived cells implicate excessive synaptic pruning during neurodevelopm...
Autores principales: | Xu, Chengai, Sellgren, Carl M., Fatouros-Bergman, Helena, Piehl, Fredrik, Blennow, Kaj, Zetterberg, Henrik, Brinkmalm, Ann, Santillo, Alexander Frizell, Lundgren, Sofia, Cervenka, Simon, Engberg, Göran, Erhardt, Sophie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7262376/ https://www.ncbi.nlm.nih.gov/pubmed/32490278 http://dx.doi.org/10.1016/j.ibror.2020.04.001 |
Ejemplares similares
-
CSF GABA is reduced in first-episode psychosis and associates to symptom severity
por: Orhan, F, et al.
Publicado: (2018) -
Plasma bilirubin levels are reduced in first-episode psychosis patients and associates to working memory and duration of untreated psychosis
por: Becklén, Meneca, et al.
Publicado: (2021) -
Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis
por: Theorell, Jakob, et al.
Publicado: (2021) -
Facial affect recognition in first-episode psychosis is impaired but not associated with psychotic symptoms()
por: Larsson, Cornelia, et al.
Publicado: (2022) -
Identification of cerebrospinal fluid and serum metabolomic biomarkers in first episode psychosis patients
por: Shang, Pei, et al.
Publicado: (2022)